Skip to content

VALIANT® Captivia VAMF3228C150TURecalls & reported problems

Medtronic, Inc. · STENT GRAFT VAMF3228C150TU VALCAP TAPER · Class 3 · Implant

All models of VALIANT Captivia (95)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
1
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00643169400139), received between Jan 28, 2019 and Jun 16, 2025 — classified as 1 death, 3 injuries.

The most frequently reported specific device problem is “Leak/Splash” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 1 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem4
  • Leak/Splash2

Patient problems

  • Hematoma1
  • Insufficient Information1
  • Intimal Dissection1
  • Pain1
  • Paralysis1
  • Rupture1
  • Unspecified Infection1
  • Vascular Dissection1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • DeathJun 16, 2025Leak/Splash; Adverse Event Without Identified Device or Use Problem; Leak/Splash; Adverse Event Without Identified Device or Use Problem

    A VALIANT CAPTIVIA STENT GRAFT WAS IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A PAU. IT WAS REPORTED THAT THE PATIENT RETURNED FIVE DAYS LATER WITH CONCERNS FOR A POSSIBLE RUPTURE. IT WAS BELIEVED AFTER A CT SCAN WAS PERFORMED, THE AORTA MAY BE MYCOTIC AND WOULD NOW BE RELINED WITH A NON-MEDTRONIC STENT GRAFT. THE PATIENT THEN PASSED AWAY ON AN UNKNOWN DATE. THE CAUSE OF DEATH IS UNKNOWN BUT IT WAS SAID THE PATIENT WAS VERY SICK WITH OTHER CO MORBIDITIES AND HAD PRE-EXISTING ADVANCED UNKNOWN TYPE OF CANCER. A POSSIBLE RUPTURE AND POSSIBLE INFECTION WERE MENTIONED AS WELL AS CONCERNS OF POSSIBLE MYCOTIC INFECTION DETERIORATING THE VALIANT CAPTIVIA GRAFT.

    Patient problems: Insufficient Information; Rupture; Unspecified Infection

    MAUDE report 22210982 ↗
  • InjuryAug 10, 2022Leak/Splash; Adverse Event Without Identified Device or Use Problem; Leak/Splash; Adverse Event Without Identified Device or Use Problem

    A VALIANT CAPTIVIA STENT GRAFT WAS IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC DISSECTION .  IT WAS REPORTED THE PATIENT PRESENTED EMERGENTLY TO ER WITH CHEST PAIN . A CT PERFORMED SHOWED THE PRESENCE OF A RETROGRADE TYPE A DISSECTION. THE PATIENT HAD OPEN ARCH SURGERY AS TREATMENT OF THE SAME DATE AND THE EVENT RESOLVED.  PER THE PHYSICIAN , IT APPEARED THE RTAD ORIGINATED AT A POINT OF CONTACT WHERE A  SUPRARENAL STENT OF THE STENT GRAFT MADE CONTACT WITH THE AORTIC ARCH AND MAY BE THE CAUSE.  NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT IS FINE.

    Patient problems: Pain; Vascular Dissection

    MAUDE report 15202367 ↗
  • InjuryMay 30, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    VALIANT NAVION STENT GRAFTS WERE IMPLANTED FOR THE ENDOVASCULAR TREATMENT OF A 200MM THORACIC AORTIC DISSECTION.  IT WAS REPORTED ON AN UNKNOWN DATE A FEW DAYS AFTER THE INDEX PROCEDURE AND SPINE DRAIN REMOVAL THE PATIENT PRESENTED WITH PARALYSIS. AS PER THE PHYSICIAN THE CAUSE OF THE EVENT MAY BE DUE TO A POSSIBLE HEMATOMA AT THE SPINAL DRAIN SITE. NO ADDITIONAL CLINICAL SEQUALAE WAS PROVIDED AND THE PATIENT WILL BE MONITORED.

    Patient problems: Hematoma; Paralysis

    MAUDE report 14540007 ↗
  • InjuryJan 28, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A VALIANT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE THORACIC ENDOVASCULAR TREATMENT OF A 300 MM ACUTE TYPE B DISSECTION THAT STARTED JUST BELOW THE LEFT SUBCLAVIAN ARTERY. DURING THE INDEX PROCEDURE VALIANT STENT GRAFT VAMF3228C150 WAS IMPLANTED AT THE PATIENTS LEFT CAROTID AFTER PERFORMING A LEFT CAROTID TO LEFT SUBCLAVIAN BYPASS. IT WAS REPORTED THE GRAFT WAS PLACED WITHOUT INCIDENCE AND AN ADDITIONAL VALIANT STENT GRAFT WAS PLACED DISTAL TO THE CELIAC TRUNK. IT WAS REPORTED THAT FINAL ANGIOGRAM SHOWED THE PATIENT HAD A TYPE A RETROGRADE DISSECTION THAT ALSO EXTENDED INTO THE INNOMINATE ARTERY. IT WAS DECIDED TO REPAIR THE ASCENDING DISSECTION. THE BARE SPRINGS OF THE VALIANT STENT GRAFT WERE REMOVED WITH WIRE CUTTERS AND A NON-MDT SYNTHETIC GRAFT WAS SEWN DIRECTLY TO THE VALIANT STENT GRAFT. THE INNOMINATE AND RIGHT CAROTID ARTERIES WERE ALSO RECONSTRUCTED. THE EVENT WAS REPORTED TO BE RESOLVED. AS PER THE PHYSICIAN, THE CAUSE OF THE EVENT WAS POSSIBLY CAUSED BY THE PROXIMAL BARE STENTS OF THE STENT GRAFT. IT WAS REPORTED THE BARE SPRING WAS IN THE INNOMINATE ARTERY AND MAY HAVE CAUSED THE DISSECTION. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS F

    Patient problems: Intimal Dissection

    MAUDE report 8280662 ↗

Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices

All SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page